Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling

Monotropein attenuates ovariectomy and LPS-induced bone loss in mice and decreases inflammatory impairment on osteoblast through blocking activation of NF-κB pathway

(2018) Yu-Qiong He et al.   CHEMICO-BIOLOGICAL INTERACTIONS

GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation

(2017) Mehdi Amirhosseini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma

(2016) Chengyu Wang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS

(2016) Haemin Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways

(2016) Lin Zhou et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition

(2016) Tao Zhang et al.   Cell Death & Disease

Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation

(2013) Seungha Hyeon et al.   FREE RADICAL BIOLOGY AND MEDICINE

Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells

(2013) Dong-Zhu Li et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Bone Modeling and Remodeling

(2012) Ego Seeman   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Isoflavones: estrogenic activity, biological effect and bioavailability

(2012) Daniela Cristina Vitale et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70

(2012) Annette I Garbe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells

(2012) Geetika Kharkwal et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Soy protein with or without isoflavones failed to preserve bone density in gonadal hormone–deficient male rat model of osteoporosis

(2012) Shanil S. Juma et al.   NUTRITION RESEARCH

Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases

(2012) J. Kikuta et al.   RHEUMATOLOGY

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Role of NF-κB in the skeleton

(2010) Deborah Veis Novack   CELL RESEARCH

Blimp1-mediated repression of negative regulators is required for osteoclast differentiation

(2010) K. Nishikawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis

(2009) HaoTian Feng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NF-κB functions in osteoclasts

(2008) N.S. Soysa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Bisphosphonate nephrotoxicity

(2008) Mark A. Perazella et al.   KIDNEY INTERNATIONAL

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

(2007) Kabsun Kim et al.   MOLECULAR ENDOCRINOLOGY